Concepedia

Erik H. Knelson

EH

Statistics

Publications

21

Citations

1.6K

H-Index

18

Active since

2010

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Harvard University

Duke Medical Center

Fox Chase Cancer Center

Erik H. Knelson is an author at Dana-Farber Cancer Institute specializing in oncology, life sciences, and medicine.

Publications per year

2010–2024

21

Publications

21

Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway

Kari J. Kurppa, Yao Liu, Ciric To et al. · Cancer Cell · 2020 · 472 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity

Navin R. Mahadevan, Erik H. Knelson, Jacquelyn O. Wolff et al. · Cancer Discovery · 2021 · 214 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models

Gilles Berger, Erik H. Knelson, Jorge L. Jimenez-Macias et al. · Proceedings of the National Academy of Sciences · 2022 · 167 citations · Full text

Medicine, Immunology, Oncology +17

MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer

Shunsuke Kitajima, Tetsuo Tani, Benjamin F. Springer et al. · Cancer Cell · 2022 · 101 citations · Full text

Medicine, Cancer Biology, Oncology +11

Activation of Tumor-Cell STING Primes NK-Cell Therapy

Erik H. Knelson, Elena V. Ivanova, Mubin Tarannum et al. · Cancer Immunology Research · 2022 · 88 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 21